PlateletWeb: A systems biologic analysis of signaling networks in human platelets

Blood

Volumn 119, Issue 3, 2012, Pages

  Boyanova, Desislava ^a   Nilla, Santosh ^a   Birschmann, Ingvild ^b   Dandekar, Thomas ^a,c   Dittrich, Marcus ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOCKING PROTEIN; DOK1 PROTEIN; INTEGRIN; PROTEIN TYROSINE KINASE; PROTEOME; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BANK; HUMAN; HUMAN TISSUE; PATHOPHYSIOLOGY; PHYLOGENY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE FUNCTION;

EID: 84856077072     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-387308     Document Type: Article

References (50)

1. Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol. 2008;28(3):403-412.
2. Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science. 2010;328(5978):562-564.
3. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;359(9):938-949.
4. Denis MM, Tolley ND, Bunting M, et al. Escaping the nuclear confines: signal-dependent premRNA splicing in anucleate platelets. Cell. 2005; 122(3):379-391. (Pubitemid 41127140)
5. Dittrich M, Birschmann I, Pfrang J, et al. Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell. Thromb Haemost. 2006;95(4):643-651.
6. Schwertz H, Tolley ND, Foulks JM, et al. Signal-dependent splicing of tissue factor premRNA modulates the thrombogenicity of human platelets. J Exp Med. 2006;203(11):2433-2440. (Pubitemid 44664613)
7. Rowley JW, Oler A, Tolley ND, et al. Genome wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood. 2011;118(14): e101-e111.
8. Dittrich M, Birschmann I, Dandekar T. Integrated platelet networks for the analysis of different system states. Current Proteomics. 2011;8(3):229-236.
9. Tuñón J, Martin-Ventura JL, Blanco-Colio LM, Lorenzo O, Lopez JA, Egido J. Proteomic strategies in the search of new biomarkers in atherothrombosis. J Am Coll Cardiol. 2010; 55(19):2009-2016.
10. Walther TC, Mann M. Mass spectrometry-based proteomics in cell biology. J Cell Biol. 2010; 190(4):491-500.
11. Senzel L, Gnatenko DV, Bahou WF. The platelet proteome. Curr Opin Hematol. 2009;16(5):329-333.
12. Zahedi RP, Lewandrowski U, Wiesner J, et al. Phosphoproteome of resting human platelets. J Proteome Res. 2008;7(2):526-534. (Pubitemid 351294015)
13. Purvis JE, Chatterjee MS, Brass LF, Diamond SL. A molecular signaling model of platelet phosphoinositide and calcium regulation during homeostasis and P2Y1 activation. Blood. 2008;112(10): 4069-4079.
14. Keshava Prasad TS, Goel R, Kandasamy K, et al. Human protein reference database - 2009 update. Nucleic Acids Res. 2009;37(database issue):D767-D772.
15. Hornbeck PV, Chabra I, Kornhauser JM, Skrzypek E, Zhang B. PhosphoSite: a bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics. 2004;4(6): 1551-1561. (Pubitemid 38738314)
16. Kanehisa M. The KEGG database. Novartis Found Symp. 2002;247:91-101; discussion 101- 103, 119-128, 244-152.
17. Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 2007;35(database issue): D26-D31.
18. Linding R, Jensen LJ, Ostheimer GJ, et al. Systematic discovery of in vivo phosphorylation networks. Cell. 2007;129(7):1415-1426. (Pubitemid 46962092)
19. Miller ML, Jensen LJ, Diella F, et al. Linear motif atlas for phosphorylation-dependent signaling. Sci Signal. 2008;1(35):ra2
20. Dittrich M, Birschmann I, Mietner S, Sickmann A, Walter U, Dandekar T. Platelet protein interactions: map, signaling components, and phosphorylation groundstate. Arterioscler Thromb Vasc Biol. 2008;28(7):1326-1331.
21. Krogh A, Larsson B, von Heijne G, Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001;305(3):567-580. (Pubitemid 33032862)
22. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298(5600): 1912-1934. (Pubitemid 35425239)
23. Letunic I, Bork P. Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics. 2007;23(1):127-128. (Pubitemid 46017867)
24. Alonso A, Sasin J, Bottini N, et al. Protein tyrosine phosphatases in the human genome. Cell. 2004; 117(6):699-711. (Pubitemid 38748887)
25. Knox C, Law V, Jewison T, et al. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011;39(database issue): D1035-D1041.
26. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-29. (Pubitemid 30257031)
27. Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess over-representation of gene ontology categories in biological networks. Bioinformatics. 2005;21(16):3448-3449. (Pubitemid 41222459)
28. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498-2504. (Pubitemid 37428274)
29. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2011.
30. Gardiner EE, Arthur JF, Shen Y, et al. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events. Platelets. 2010;21(4):244-252.
31. Liu BA, Jablonowski K, Raina M, Arce M, Pawson T, Nash PD. The human and mouse complement of SH2 domain proteins: establishing the boundaries of phosphotyrosine signaling. Mol Cell. 2006; 22(6):851-868.
32. Almén MS, Nordstrom KJ, Fredriksson R, Schioth HB. Mapping the human membrane proteome: a majority of the human membrane proteins can be classified according to function and evolutionary origin. BMC Biol. 2009;7:50.
33. Wegener KL, Partridge AW, Han J, et al. Structural basis of integrin activation by talin. Cell. 2007;128(1):171-182. (Pubitemid 46048890)
34. Songyang Z, Yamanashi Y, Liu D, Baltimore D. Domain-dependent function of the rasGAPbinding protein p62Dok in cell signaling. J Biol Chem. 2001;276(4):2459-2465.
35. Calderwood DA, Fujioka Y, de Pereda JM, et al. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc Natl Acad Sci U S A. 2003;100(5):2272-2277. (Pubitemid 36297489)
36. Oxley CL, Anthis NJ, Lowe ED, Vakonakis I, Campbell ID, Wegener KL. An integrin phosphorylation switch: the effect of beta3 integrin tail phosphorylation on Dok1 and talin binding. J Biol Chem. 2008;283(9):5420-5426.
37. Obara Y, Labudda K, Dillon TJ, Stork PJ. PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J Cell Sci. 2004;117(25):6085-6094. (Pubitemid 40123973)
38. Datta A, Huber F, Boettiger D. Phosphorylation of beta3 integrin controls ligand binding strength. J Biol Chem. 2002;277(6):3943-3949. (Pubitemid 34968647)
39. Bullock AN, Das S, Debreczeni JE, et al. Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation. Structure. 2009;17(3):352-362.
40. Spyridon M, Moraes LA, Jones CI, et al. LXR as a novel antithrombotic target. Blood. 2011;117(21): 5751-5761.
41. Moraes LA, Barrett NE, Jones CI, et al. Platelet endothelial cell adhesion molecule-1 regulates collagen-stimulated platelet function by modulating the association of phosphatidylinositol 3- kinase with Grb-2-associated binding protein-1 and linker for activation of T cells. J Thromb Haemost. 2010;8(11):2530-2541.
42. Dittrich M, Strassberger V, Fackler M, et al. Characterization of a novel interaction between vasodilator- stimulated phosphoprotein and Abelson interactor 1 in human platelets: a concerted computational and experimental approach. Arterioscler Thromb Vasc Biol. 2010;30(4):843-850.
43. Vogler M, Hamali HA, Sun XM, et al. BCL2/ BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood. 2011;117(26):7145-7154.
44. Melnikova I, Golden J. Targeting protein kinases. Nat Rev Drug Discov. 2004;3(12):993-994. (Pubitemid 39642356)
45. Seligsohn U. Glanzmann thrombasthenia: a model disease which paved the way to powerful therapeutic agents. Pathophysiol Haemost Thromb. 2002;32(5):216-217. (Pubitemid 37490541)
46. Shattil SJ. The beta3 integrin cytoplasmic tail: protein scaffold and control freak. J Thromb Haemost. 2009;7(suppl 1):210-213.
47. Némorin JG, Laporte P, Berube G, Duplay P. p62dok negatively regulates CD2 signaling in Jurkat cells. J Immunol. 2001;166(7):4408-4415. (Pubitemid 32233723)
48. Senis YA, Antrobus R, Severin S, et al. Proteomic analysis of integrin alphaIIbbeta3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions. J Thromb Haemost. 2009;7(10):1718-1726.
49. Moeslein FM, Myers MP, Landreth GE. The CLK family kinases, CLK1 and CLK2, phosphorylate and activate the tyrosine phosphatase, PTP-1B. J Biol Chem. 1999;274(38):26697-26704.
50. Hughan SC, Watson SP. Differential regulation of adapter proteins Dok2 and Dok1 in platelets, leading to an association of Dok2 with integrin alphaIIbbeta3. J Thromb Haemost. 2007;5(2): 387-394. (Pubitemid 46139465)